Top Markets
#1 0G 0G +43.07%
#2 Merlin's Seal BTC Merlin's Seal BTC +42.87%
#3 Useless Coin Useless Coin +29.81%
#4 SAFEcoin SAFEcoin +28.61%
#5 StonkBroker StonkBroker +28.19%
#6 Pons Pons +24.78%
#7 Zora Zora +21.88%
#8 Dogs Dogs +20.90%
#9 ICON ICON +20.51%
#10 Dash Dash +18.26%
Coin of the day
0G 0G
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Beijing Leadman Biochemistry Co.,Ltd. Beijing Leadman Biochemistry Co.,Ltd.

Beijing Leadman Biochemistry Co.,Ltd.

300289
Classifica tra le azioni #13635
Beijing Leadman Biochemistry Co.,Ltd. is a prominent entity within the People's... Beijing Leadman Biochemistry Co.,Ltd. is a prominent entity within the People's Republic of China, specializing in the entire lifecycle – from research and development to manufacturing and distribution – of advanced in vitro diagnostic (IVD) solutions. Its product portfolio encompasses a comprehensive range of biochemical raw materials. This includes critical components like enzymes, coenzymes, antibodies, various buffers, enzyme substrates, culture media, staining reagents, and amino acids. These essential ingredients serve a diverse array of sectors, notably biotechnology, clinical diagnostics, pharmaceutical development, and chemical manufacturing. Beyond raw materials, Leadman also provides specialized biochemistry diagnostic and complementary reagents. Furthermore, the company supplies a sophisticated selection of medical instrumentation. This lineup features the EnigmaML, an automated molecular testing platform designed for both clinical laboratories and various point-of-care settings like clinics and pharmacies. Another key offering is the DiaSys InnovaStar, a compact automated POCT analyzer that delivers laboratory-grade diagnostic accuracy. Customers also benefit from the DiaSys Respons, a versatile random access benchtop analyzer; the CI1000 automatic chemiluminescence immunoassay analyzers; and the IDS-isys, an instrument engineered to boost operational performance and efficiency. Established in 1997, Beijing Leadman Biochemistry maintains its corporate headquarters in Beijing, China.
Prezzo delle azioni
$0.87093245
Capitalizzazione di mercato
$473.80M
Variazione (1 giorno)
-1.48%
Variazione (1 anno)
-24.54%
Paese
CN
Scambia Beijing Leadman Biochemistry Co.,Ltd. (300289)

Categoria

Healthcare
Ricavi di Beijing Leadman Biochemistry Co.,Ltd. (300289)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Beijing Leadman Biochemistry Co.,Ltd., i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Beijing Leadman Biochemistry Co.,Ltd. da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B -
US